005690.KS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 14:30):

Stats
今日成交量	140 438
平均成交量	703 858
市值	349.22B
EPS	KRW0 ( 2024-02-12 )
下一个收益日期	( KRW0 ) 2024-05-12
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW13.13 (0.23%)

音量相关性

長: 0.23 (neutral)

短: -1.00 (very strong negative)

Signal:(46.043) Neutral

Pharmicell Co., Ltd. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Pharmicell Co., Ltd. 相关性 - 货币/商品

-0.16
( neutral )

-0.06
( neutral )

-0.01
( neutral )

0.28
( neutral )

0.40
( neutral )

0.05
( neutral )

Pharmicell Co., Ltd. 财务报表

Annual	2023
营收:	KRW56.23B
毛利润:	KRW14.96B (26.60 %)
EPS:	KRW59.63

FY	2023
营收:	KRW56.23B
毛利润:	KRW14.96B (26.60 %)
EPS:	KRW59.63

FY	2022
营收:	KRW60.18B
毛利润:	KRW23.82B (39.58 %)
EPS:	KRW137.79

FY	2021
营收:	KRW50.89B
毛利润:	KRW23.46B (46.09 %)
EPS:	KRW158.70

Financial Reports:

No articles found.

Pharmicell Co., Ltd.

Pharmicell Co., Ltd., a biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally. The company operates in Biopharmaceutical Business and Biochemical Business divisions. It offers Cellgram_AMI that is manufactured using autologous bone marrow-derived mesenchymal stem cell to enhance the ejection fraction in patients with acute myocardial infarction reperfused by coronary angioplasty. The company's products under development include Cellgram_LC, a liver disease drug; Cellgram_ED for treating impotence; and Cellgram_DC, a cancer drug, as well as Hearticellgram_AM, a cardiac disease drug. It also develops and produces intermediates of raw material medicines, such as nucleosides, mPEGs, HDP-tosylate, and vincelactam; and low dielectric constant material, eco-friendly flame retardant, polyol synthesis catalyst, PET catalyst, etc. In addition, the company operates Twelve, a stem cell bank; develops and sells stem cell culture media cosmetics. Pharmicell Co., Ltd. was founded in 2002 and is headquartered in Seoul, South Korea.